リキッドバイオプシーの世界市場予測（～2021）...市場調査レポートについてご紹介

1 Introduction (Page No. – 15)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Markets Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 18)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.2.1 Key Data From Secondary Sources
2.2.2 Key Data From Primary Sources
2.2.3 Assumptions for the Study

3 Executive Summary (Page No. – 26)
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights (Page No. – 31)
4.1 Liquid Biopsy: Market Overview
4.2 Geographic Analysis: Liquid Biopsy Market, By Circulating Biomarker
4.3 Market Size, By End User, 2016 vs 2021
4.4 Market Size, By Product, 2016 vs 2021
4.5 Market Size, By Circulating Biomarker, 2016 vs 2021
4.6 Geographical Snapshot of the Market

5 Market Overview (Page No. – 36)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Increasing Number of New Cancer Cases
5.2.1.2 Benefits of Liquid Biopsy Over Surgical Biopsy
5.2.1.3 Technological Advancements to Boost Market Growth
5.2.1.4 Availability of Funding for Liquid Biopsy Research
5.2.1.5 Initiatives to Increase Awareness on Liquid Biopsy
5.2.2 Market Restraints
5.2.2.1 Low Sensitivity and Specificity
5.2.3 Market Opportunities
5.2.3.1 Focus on Inorganic Strategies
5.2.4 Market Challenges
5.2.4.1 Unclear Regulatory and Reimbursement Scenario

6 Industry Insights (Page No. – 45)
6.1 Introduction
6.2 Regulatory Approval Process
6.3 Major Ongoing Clinical Trials in the Market
6.4 Major Funding Activities in the Market

7 Liquid Biopsy Market, By Cancer Type (Page No. – 54)
7.1 Introduction
7.1.1 Lung Cancer
7.2 Breast Cancer
7.2.1 Colorectal Cancer
7.2.2 Prostate Cancer
7.2.3 Liver Cancer
7.2.4 Other Cancers

8 Liquid Biopsy Market, By Circulating Biomarker (Page No. – 69)
8.1 Introduction
8.2 Circulating Tumor Cells
8.3 Extracellular Vesicles
8.4 Circulating Tumor DNA (CTDNA)
8.5 Other Biomarkers

9 Liquid Biopsy Market, By Products and Services (Page No. – 79)
9.1 Introduction
9.1.1 Reagents
9.2 Instruments
9.2.1 Services & Software

10 Liquid Biopsy Market, By End User (Page No. – 87)
10.1 Introduction
10.2 Reference Laboratories
10.2.1 Hospitals and Physician Laboratories
10.2.2 Academic and Research Centers
10.2.3 Other End Users

11 Liquid Biopsy Market, By Region (Page No. – 95)
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.4 Asia-Pacific
11.5 Rest of the World (RoW)

12 Competitive Landscape (Page No. – 121)
12.1 Overview
12.2 Competitive Situation and Trends
12.2.1 Agreements, Partnerships, and Collaborations
12.2.2 New Product Launches
12.2.3 Acquisitions
12.2.4 Other Developments

13 Company Profiles (Page No. – 128)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
13.1 Introduction
13.2 Biocept, Inc.
13.3 Qiagen
13.4 F. Hoffmann-La Roche AG
13.5 Bio-Rad Laboratories Inc.
13.6 Myriad Genetics
13.7 Janssen Diagnostics, LLC.
13.8 Tr0vagene Inc.
13.9 Guardant Health Inc.
13.10 Fraunhofer-Gesellschaft
13.11 MDX Health SA

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. – 150)
14.1 Insights of Industry Experts
14.2 Discussion Guide
14.3 Other Developments
14.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
14.5 Introducing RT: Real-Time Market Intelligence
14.6 Available Customizations
14.7 Related Reports